5-methylaminomethyl-2-thiouridylate

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Arranz, Jose Antonio: 1 article (03/2021)
2.	Carnicer, Clara: 1 article (03/2021)
3.	Carreño, Lidia: 1 article (03/2021)
4.	Del Toro, Mireia: 1 article (03/2021)
5.	Garcia-Arumi, Elena: 1 article (03/2021)
6.	Gort, Laura: 1 article (03/2021)
7.	Lasa-Aranzasti, Amaia: 1 article (03/2021)
8.	Miguel, Lucía Dougherty-de: 1 article (03/2021)
9.	Sala-Coromina, Júlia: 1 article (03/2021)
10.	Sanchez-Montañez, Angel: 1 article (03/2021)

1.	Liver Failure 01/01/2015 - "Recently pathogenic mutations in tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) gene (OMIM 610230) have been demonstrated to cause transient infantile liver failure (OMIM 613070). " 05/01/2015 - "Another mitochondrial disease due to deficiency of the 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) causes severe liver failure in infancy, but similar to the reversible mitochondrial myopathy, within the first year of life these infants may also recover completely. "
2.	Mitochondrial Diseases (Mitochondrial Disease) 05/01/2015 - "Another mitochondrial disease due to deficiency of the 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) causes severe liver failure in infancy, but similar to the reversible mitochondrial myopathy, within the first year of life these infants may also recover completely. "
3.	Mitochondrial Myopathies (Mitochondrial Myopathy) 05/01/2015 - "Another mitochondrial disease due to deficiency of the 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) causes severe liver failure in infancy, but similar to the reversible mitochondrial myopathy, within the first year of life these infants may also recover completely. "
4.	Acute Liver Failure (Fulminant Hepatic Failure) 03/01/2021 - "tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) deficiency causes an early onset potentially reversible acute liver failure, so far reported in less than 30 patients. "